ixekizumab

Trials studying ixekizumab

• phase1A Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of SB35 (Proposed Ixekizumab Biosimilar) to Taltz in Healthy Participantsnot yet recruitingn=174
• phase3A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapyactive not recruitingn=308
• phase3A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritisactive not recruitingn=101
• N/ACombination of Biologic and Anti-obesity Therapies in Psoriatic Arthritisnot yet recruitingn=45
• phase3Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweightactive not recruitingn=279
• phase3Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweightactive not recruitingn=250
• phase1Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjectsactive not recruitingn=218
• phase4A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in Indiacompletedn=250